Updates are available Correction dated 2021-02-19
Click to view Correction: https://doi.org/10.1038/s41580-021-00353-x
-
Authors
Lim, Ci Ji http://orcid.org/0000-0003-3327-1926
Cech, Thomas R. http://orcid.org/0000-0001-7338-3389
- License Information
-
More Information
Article History
Accepted: 4 January 2021
First Online: 9 February 2021
Change Date: 19 February 2021
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41580-021-00353-x
Competing interests
: T.R.C. is on the board of directors of Merck and a consultant for STORM Therapeutics and Eikon Therapeutics.
